Calciphylaxis: a systematic review of existing and emerging therapies.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 21821309.
- Also identified by DOI 10.1016/j.jaad.2011.06.009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Calciphylaxis, also known as calcific uremic arteriolopathy, is a cutaneous ischemic small vessel vasculopathy seen in 1 to 4% of patients with chronic kidney disease on hemodialysis. It is associated with extreme pain and a 60 to 80% mortality rate in the setting of few and frequently ineffective therapeutic options, although this may be changing based on reports of success with newer therapies.
Medical subject headings
- Calciphylaxis
- Skin Diseases, Vascular